Top 10 Contract Development and Manufacturing Organizations 2026
Alex Philippidis analyzes the top CDMOs this year, noting a bright future as biopharma is expected to increase their reliance on CDMOs in coming years despite rising costs for their services. Which companies made the top 10 list? Check out the list to find out.
10 CDMO Up & Comers 2026
As one notable company exits the field, growing CDMOs open facilities and secure major contracts. The companies are listed here for making headlines with facility openings, major contracts, and other significant actions, though not yet large enough to crack the A-List Top 10 CDMOs.
Next 10 U.S. Biopharma Clusters
For the first time, GEN‘s Alex Philippidis examines the top regions and top states just below the 10 largest regions for life sciences activity, as the field looks beyond the East and West Coasts for growth.
GEN Digital Edition
Access the latest issue of GEN and browse the archive of back issues when you subscribe to our digital edition.
Advancing Microbial-Derived Biologics from Scale-Up to Commercial Production
In this GEN webinar, our expert speaker, Sam Zhang, PhD, will discuss emerging trends and capacity needs across the global late-stage microbial pipeline and CDMO landscape.
Sam Zhang, PhD
VP, Head of Microbial, HEK293, and in vivo CAR Platforms
WuXi Biologics
One Standard, Multiple Platforms: ICH Q2(R2) Qualification of Host Cell Protein Analysis by LC–MS/MS
Is Targeted Protein Degradation the “Break” Neurology Needs?
Right Resin, Right Order: A Two-Step Polishing Strategy for Bispecific Antibodies
The Next Wave of ADC Innovation: The Science Behind Dual-Payload Bioconjugates
Podcast
Touching Base
Touching Base is the dynamic podcast series from the editors of GEN. Each episode features a rotating case of senior editors—including John Sterling, Kevin Davies, Julianna LeMieux, Alex Phillippidis, Uduak Thomas, Corinna Singleman, and Fay Lin—who delve into emerging stories, exchange ideas, and debate the latest trends in biotech. Additionally, they talk to some of the leading voices in the industry about what’s now and next. Start listening today!
Stay up to date with the lasted episodes of Touching Base by subscribing to the GEN Podcast Newsletter
StockWatch: Novo’s 2030 Strategy Underwhelms Investors at Capital Markets Day
Lilly’s GIP/GLP-1 Candidate Brenipatide Shows Early Clinical Promise in Substance, Psych Disorders
